Agios Pharmaceuticals Overview
Agios Pharmaceuticals Target Price
Analysts' 12-month price predictions for AGIO.
Share Price
$28.03
Average Target Price
$71.00
153.3% upside
153.3% upside1 analysts in the last 4 months
High: $71 | Low: $71
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-02 | ScotiabankGreg Harrison | $71 | 153.3% upside |  |
| 2024-10-31 | Raymond JamesDanielle Brill | $51 | 81.9% upside | |
| 2024-09-27 | Leerink PartnersAndrew Berens | $56 | 99.8% upside | |
| 2024-09-10 | Raymond JamesChris Raymond | $56 | 99.8% upside | |
| 2024-06-17 | Raymond JamesChris Raymond | $55 | 96.2% upside | |
| 2024-06-03 | RBC CapitalGregory Renza | $53 | 89.1% upside | |
| 2024-05-28 | Raymond JamesChris Raymond | $45 | 60.5% upside | |
| 2023-02-03 | Piper Sandler | $41 | 46.3% upside | |
| 2022-12-01 | J.P. Morgan | $33 | 17.7% upside | |
| 2022-11-17 | Goldman Sachs | $32 | 14.2% upside | |
| 2021-04-30 | BarclaysPeter Lawson | $70 | 149.7% upside | |